NR4A1 and cancer: In order to achieve clinically relevant models, it will be necessary to bring together the best of both worlds: large models able to integrate most alterations of common cancer pathways (e.g., DNA repair) and cancer-specific nodes (e.g., hormone receptors) able to explain the particular behavior of each cancer.